Company:  WARNER CHILCOTT PLC
Form Type:  8-K
Filing Date:  8/7/2012 
CIK:  0001323854 
Address:  1 GRAND CANAL SQUARE 
City, State, Zip:  DOCKLANDS, DUBLIN 2, IRELAND,  00000 
Telephone:  353 1 897 2000 
Fiscal Year:  12/31 
Description of Business
We are a leading specialty pharmaceutical company currently focused on the women�s healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America. We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. Our franchises are comprised of complementary portfolios of established branded and development-stage products that we actively manage throughout their life cycles. Multiple products make up our existing sales base and several of these provide opportunities for future growth. Our women�s healthcare franchise is anchored by our strong presence in the hormonal contraceptive, osteoporosis and hormone therapy (�HT�) markets. Our hormonal contraceptive product offerings include: LOESTRIN 24 FE (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), the leading branded product in the U.S.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 7 REGULATION FD
      Item 7.01 Regulation FD Disclosure
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 99.1
BROKERAGE PARTNERS